Heart Failure With Preserved Ejection Fraction
Authors:
- 20 October 2020
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA
- Vol. 324 (15) , 1506-1508
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Heart Failure With Preserved Ejection Fraction In PerspectiveCirculation Research, 2019
- HFpEF, a Disease of the Vasculature: A Closer Look at the Other HalfMayo Clinic Proceedings, 2018
- Heart Failure With Preserved Ejection Fraction Expert Panel ReportJACC: Heart Failure, 2018
- 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart FailureJACC, 2017
- Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) studyEuropean Heart Journal, 2017
- Phenotype-Specific Treatment of Heart Failure With Preserved Ejection FractionCirculation, 2016
- Obesity and natriuretic peptides, BNP and NT-proBNP: Mechanisms and diagnostic implications for heart failureInternational Journal of Cardiology, 2014
- Soluble guanylate cyclase: a potential therapeutic target for heart failureHeart Failure Reviews, 2012
- Body Mass Index and Adverse Cardiovascular Outcomes in Heart Failure Patients With Preserved Ejection FractionCirculation: Heart Failure, 2011
- Quantitative Evaluation of Drug or Device Effects on Ventricular Remodeling as Predictors of Therapeutic Effects on Mortality in Patients With Heart Failure and Reduced Ejection FractionJACC, 2010